• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Oct 14:15:1440324.
doi: 10.3389/fimmu.2024.1440324. eCollection 2024. Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain

Cordelia Dunai[SUP] 1 2 [/SUP], Claire Hetherington[SUP] 2 [/SUP], Sarah A Boardman[SUP] 2 [/SUP], Jordan J Clark[SUP] 3 [/SUP], Parul Sharma[SUP] 3 [/SUP], Krishanthi Subramaniam[SUP] 3 [/SUP], Kukatharmini Tharmaratnam[SUP] 4 [/SUP], Edward J Needham[SUP] 5 [/SUP], Robyn Williams[SUP] 6 [/SUP], Yun Huang[SUP] 2 [/SUP], Greta K Wood[SUP] 2 [/SUP], Ceryce Collie[SUP] 2 [/SUP], Andrew Fower[SUP] 6 [/SUP], Hannah Fox[SUP] 6 [/SUP], Mark A Ellul[SUP] 2 [/SUP], Marie Held[SUP] 7 [/SUP], Franklyn N Egbe[SUP] 2 [/SUP], Michael Griffiths[SUP] 2 [/SUP], Tom Solomon[SUP] 1 2 8 [/SUP], Gerome Breen[SUP] 9 10 [/SUP], Anja Kipar[SUP] 3 11 [/SUP], Jonathan Cavanagh[SUP] 12 [/SUP], Sarosh R Irani[SUP] 8 [/SUP], Angela Vincent[SUP] 6 [/SUP], James P Stewart[SUP] 3 [/SUP], Leonie S Taams[SUP] #[/SUP][SUP] 13 [/SUP], David K Menon[SUP] #[/SUP][SUP] 14 [/SUP], Benedict D Michael[SUP] #[/SUP][SUP] 1 2 8 [/SUP]



Affiliations
Abstract

Neurological complications, including encephalopathy and stroke, occur in a significant proportion of COVID-19 cases but viral protein is seldom detected in the brain parenchyma. To model this situation, we developed a novel low-inoculum K18-hACE2 mouse model of SARS-CoV-2 infection during which active viral replication was consistently seen in mouse lungs but not in the brain. We found that several mediators previously associated with encephalopathy in clinical samples were upregulated in the lung, including CCL2, and IL-6. In addition, several inflammatory mediations, including CCL4, IFNγ, IL-17A, were upregulated in the brain, associated with microglial reactivity. Parallel in vitro experiments demonstrated that the filtered supernatant from SARS-CoV-2 virion exposed brain endothelial cells induced activation of uninfected microglia. This model successfully recreates SARS-CoV-2 virus-associated para-infectious brain inflammation which can be used to study the pathophysiology of the neurological complications and the identification of potential immune targets for treatment.

Keywords: SARS-CoV-2; immunology; microglia; neurology; virology.

 
Back
Top Bottom